Our eleventh AMR Action Podcast features an interview with Dr. Andrew Morris, Chair of the Council of Canadian Academies (CCA) Expert Panel on Antimicrobial Availability to discuss the CCA’s newly released report, Overcoming Resistance. The report, commissioned by the Public Health Agency of Canada, describes the pull incentives that could help boost the availability of novel antimicrobials to counter the rise in antimicrobial resistance (AMR).

Dr. Morris is the Medical Director of the Antimicrobial Stewardship Program Sinai Health/University Health Network and Professor, Department of Medicine Faculty of Medicine at the University of Toronto.

In this tenth episode of the AMR Action Podcast, Dani Peters, CAIC Senior Advisor, speaks with Dr. Curtis Nickel, Professor Emeritus, Department of Urology, Queen’s University and Kingston Health Sciences Centre, on the issue of urinary tract infections (UTIs), and why recurring UTIs present a public health issue, especially within the context of rising rates of antimicrobial resistance (AMR).

In this ninth episode of the AMR Action Podcast, Dani Peters, CAIC Senior Advisor, speaks with Dr. Sue Twine, National Research Council of Canada’s Director General of the Human Health Therapeutics Research Centre, and researchers Dr. Danielle Peters and Alyssa McAdorey, about their work to address the growing public health threat of antimicrobial resistance and the importance of collaborating across institutions and industry in order to tackle the “next big silent pandemic.”

Dr. Henry Skinner, CEO of the AMR Action Fund, joins Dani Peters, CAIC Senior Advisor, during World Antimicrobial Awareness Week to discuss the status of the global campaign to combat antimicrobial resistance in this 8th episode of the AMR Action Podcast. Dr. Skinner shares his perspective on the challenges with the broken market, and the barriers that need to be overcome in order to expedite innovation for new antimicrobials. He also discusses incentive models for policy makers and why more robust investments are needed from the private sector. Finally, he shares his optimism stemming from new technologies that are being tested and supported through the AMR Action Fund.